[The suppression of bronchospasm with disodium cromoglycate (DSCG) (author's transl)].
The protective effect of DSCG (disodium cromoglycate) was tested in 23 patients with artificial bronchospasm induced by specific allergen. After premedication with DSCG there was no arise of airway resistance (Rt) in 11 of 23 patients. In 4 patients with significant bronchial reaction, spontaneous remission could be registrated. In 8 patients DSCG could not suppress artificial bronchospasm. The clinically relevant aspects of these findings are being discussed.
D000293:Adolescent; D000328:Adult; D001249:Asthma / Q000188:drug therapy; D001986:Bronchial Spasm / Q000188:drug therapy*; D002648:Child; D004205:Cromolyn Sodium / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D012130:Respiratory Hypersensitivity / Q000188:drug therapy*; D012221:Rhinitis, Allergic, Perennial / Q000188:drug therapy
D004205:Cromolyn Sodium
Dinatrium cromoglicicum (DNCG) zur Suppression des spezifisch induzierten Bronchospasmus.